Category Archives: Presentations

Tesamorelin Clinical Data Overview

ECAB_AOP_Thera_July62016_Medical

Also posted in Uncategorized | Comments closed

UK-CAB 59: HIV and the brain

Friday 8 July 2016 Venue Hotel Details Expenses Programme 09.45-10.00 Welcome and introductions, UK-CAB updates, company pre-meeting 10.00-10.30  BME access to mental health care in Leicester – Johnson Mwangi 10.30-11.15 HIV neurology – Dr Nick Davies, Chelsea and Westminster Hospital 11.15-11.30 BREAK 11.30-12.30 Cognitive impairment in well treated cohorts – Dr Jonathan Underwood, Imperial College London and Imperial College […]

Also posted in Meetings | Comments closed

UK-CAB PrEP statement (June 2016)

The UK Community Advisory Board (UK-CAB, the network for community HIV treatment advocates) is extremely disappointed by NHS England’s renewed refusal to commission pre-exposure prophylaxis (PrEP) for people at high risk of acquiring HIV. Currently, 17 people are diagnosed with HIV every day in the UK – the majority in England. By commissioning PrEP, NHS England could prevent […]

Also posted in News | Comments closed

UK-CAB 58: HIV and hormonal therapy

Friday 29 April 2016 Venue Hotel Details Expenses  Programme 09.30-09.45 Arrival 09.45-10.00 Welcome and introductions, UK-CAB updates 10.00-10.45 HIV and menopause – Shema Tariq 10.45-11.15 Community engagement on BHIVA guidelines – Robert James 11.15-11.30 BREAK 11.30-12.30 Personal experience: Trans*woman – Catalina Hermes 12.30-14.00 LUNCH 14.00-15.30 Community response to NHS PrEP reconsideration –NATAgeing conference feedback – Damian Kelly 15.30-15.40 BREAK 15.40-16.15 […]

Also posted in Meetings | Comments closed

Presentations from 2014 treatment activism training

Day 1 – Wednesday 3 September 2014 Introduction to science and research introduction – Simon Collins, [PDF] Tips for writing – Simon Collins, [PDF] Reading material: Clinical trials: a community guide to HIV research (2009) ………………………………………………………………………………………………………………………….  Day 2 – Thursday 4 September 2014 Session 1: Defining a research question and defining endpoints – Colette Smith, [Powerpoint] Session 2: What study design […]

Also posted in Training | Comments closed

CAB41 presentations from meeting

TB and HIV – treatment and screening Strengething community response to TB-HIV

Posted in Presentations | Comments closed

Access To Treatment For Visitors

THT CASE STUDIES February 2000: a woman from an East African country who was not entitled to free NHS treatment told THT that she had been diagnosed at a London hospital where a midwife had unofficially given her some “medicines” but was unable to offer ongoing treatment. It was unclear what the offered “medicines” were. […]

Posted in Presentations | Comments closed

TB and HIV coinfection

This is a report of the training session on TB and HIV coinfection that was given to the UK-CAB by Dr Anton Pozniak. Reading material for this meeting and the slide set are on the i-Base website. Report by Simon Collins.

Posted in Presentations | Comments closed

Issues of working with HIV positive refugees and asylum seekers

This is a transcription of the training session on access to treatment that was given to the UK-CAB by Badru Male and Linda McDonald. Reading material for this meeting and the slide set are on the i-Base website. Report edited by Simon Collins.

Posted in Presentations | Comments closed

Hepatitis C and HCV/HIV Coinfection – from NATAP (June 2002)

http://www.natap.org/2002/june/hep62402.htm natural course of history of disease progression in HCV and HCV/HIV coinfection Transmission of HCV Testing: genotype, viral load, genotype, stopping therapy at week 12 or 24 diagnostic tests: understanding the biopsy, ALT treatment for HCV in mono- and coinfected patients how does HAART affect the liver and what you can do about it […]

Also posted in Background reading | Comments closed